The transcriptional repression activity of STAF65γ is facilitated by promoter tethering and nuclear import of class IIa histone deacetylases

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 7, 2014, Pages 579-591

  Hsieh, Feng Shu ^a   Chen, Nai Tzu ^a   Yao, Ya Li ^b   Wang, Shi Yun ^a   Chen, Jeremy J W ^a   Lai, Chien Chen ^a   Yang, Wen Ming ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

Histone deacetylases; Lung adenocarcinoma; STAF65 ; Transcriptional regulation; YY1

Indexed keywords

COREPRESSOR PROTEIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 2A; STAF 65 GAMMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; GENE REPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MALE; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SUMOYLATION;

HISTONE DEACETYLASES; LUNG ADENOCARCINOMA; STAF65Γ; TRANSCRIPTIONAL REGULATION; YY1;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; ADULT; AGED; CELL CYCLE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SUMOYLATION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; YY1 TRANSCRIPTION FACTOR;

EID: 84901595749     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.05.007     Document Type: Article

References (58)

1. Lin C.Y., Loven J., Rahl P.B., Paranal R.M., Burge C.B., Bradner J.E., Lee T.I., Young R.A. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
2. Bywater M.J., Pearson R.B., McArthur G.A., Hannan R.D. Dysregulation of the basal RNA polymerase transcription apparatus in cancer. Nat. Rev. Cancer 2013, 13:299-314.
3. Nishizaka S., Gomi S., Harada K., Oizumi K., Itoh K., Shichijo S. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma. Cancer Res. 2000, 60:4830-4837.
4. Martinez E., Palhan V.B., Tjernberg A., Lymar E.S., Gamper A.M., Kundu T.K., Chait B.T., Roeder R.G. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol. Cell. Biol. 2001, 21:6782-6795.
5. Spedale G., Timmers H.T., Pijnappel W.W. ATAC-king the complexity of SAGA during evolution. Genes Dev. 2012, 26:527-541.
6. Wu P.Y., Winston F. Analysis of Spt7 function in the Saccharomyces cerevisiae SAGA coactivator complex. Mol. Cell. Biol. 2002, 22:5367-5379.
7. Liu X., Vorontchikhina M., Wang Y.L., Faiola F., Martinez E. STAGA recruits mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol. Cell. Biol. 2008, 28:108-121.
8. Gamper A.M., Roeder R.G. Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage. Mol. Cell. Biol. 2008, 28:2517-2527.
9. Lai I.L., Wang S.Y., Yao Y.L., Yang W.M. Transcriptional and subcellular regulation of the TRIP-Br family. Gene 2007, 388:102-109.
10. Soutoglou E., Demeny M.A., Scheer E., Fienga G., Sassone-Corsi P., Tora L. The nuclear import of TAF10 is regulated by one of its three histone fold domain-containing interaction partners. Mol. Cell. Biol. 2005, 25:4092-4104.
11. Demeny M.A., Soutoglou E., Nagy Z., Scheer E., Janoshazi A., Richardot M., Argentini M., Kessler P., Tora L. Identification of a small TAF complex and its role in the assembly of TAF-containing complexes. PLoS One 2007, 2:e316.
12. Yao Y.L., Yang W.M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J. Biol. Chem. 2003, 278:42560-42568.
13. Jiang W., Zhou L., Breyer B., Feng T., Cheng H., Haydon R., Ishikawa A., He T.C. Tetracycline-regulated gene expression mediated by a novel chimeric repressor that recruits histone deacetylases in mammalian cells. J. Biol. Chem. 2001, 276:45168-45174.
14. Kao H.Y., Downes M., Ordentlich P., Evans R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 2000, 14:55-66.
15. Hu E., Chen Z., Fredrickson T., Zhu Y., Kirkpatrick R., Zhang G.F., Johanson K., Sung C.M., Liu R., Winkler J. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J. Biol. Chem. 2000, 275:15254-15264.
16. Ling Y., Sankpal U.T., Robertson A.K., McNally J.G., Karpova T., Robertson K.D. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res. 2004, 32:598-610.
17. Yang W.M., Inouye C., Zeng Y., Bearss D., Seto E. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:12845-12850.
18. Yang W.M., Tsai S.C., Wen Y.D., Fejer G., Seto E. Functional domains of histone deacetylase-3. J. Biol. Chem. 2002, 277:9447-9454.
19. Lai I.L., Lin T.P., Yao Y.L., Lin C.Y., Hsieh M.J., Yang W.M. Histone deacetylase 10 relieves repression on the melanogenic program by maintaining the deacetylation status of repressors. J. Biol. Chem. 2010, 285:7187-7196.
20. Yao Y.L., Yang W.M., Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 2001, 21:5979-5991.
21. Yao Y.L., Dupont B.R., Ghosh S., Fang Y., Leach R.J., Seto E. Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. Nucleic Acids Res. 1998, 26:3776-3783.
22. Li Y., Slansky J.E., Myers D.J., Drinkwater N.R., Kaelin W.G., Farnham P.J. Cloning, chromosomal location, and characterization of mouse E2F1. Mol. Cell. Biol. 1994, 14:1861-1869.
23. Ji C., Casinghino S., McCarthy T.L., Centrella M. Cloning, characterization, and expression of the transforming growth factor-beta type I receptor promoter in fetal rat bone cells. J. Cell. Biochem. 1996, 63:478-490.
24. Liang Y.C., Hsu C.Y., Yao Y.L., Yang W.M. PARP-2 regulates cell cycle-related genes through histone deacetylation and methylation independently of poly(ADP-ribosyl)ation. Biochem. Biophys. Res. Commun. 2013, 431:58-64.
25. Hsieh M.J., Yao Y.L., Lai I.L., Yang W.M. Transcriptional repression activity of PAX3 is modulated by competition between corepressor KAP1 and heterochromatin protein 1. Biochem. Biophys. Res. Commun. 2006, 349:573-581.
26. Yang W.M., Yao Y.L., Seto E. The FK506-binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1. EMBO J. 2001, 20:4814-4825.
27. Shedden K., Taylor J.M., Enkemann S.A., Tsao M.S., Yeatman T.J., Gerald W.L., Eschrich S., Jurisica I., Giordano T.J., Misek D.E., Chang A.C., Zhu C.Q., Strumpf D., Hanash S., Shepherd F.A., Ding K., Seymour L., Naoki K., Pennell N., Weir B., Verhaak R., Ladd-Acosta C., Golub T., Gruidl M., Sharma A., Szoke J., Zakowski M., Rusch V., Kris M., Viale A., Motoi N., Travis W., Conley B., Seshan V.E., Meyerson M., Kuick R., Dobbin K.K., Lively T., Jacobson J.W., Beer D.G. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 2008, 14:822-827.
28. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
29. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010, 17:1471-1474.
30. Rabbitts P.H., Watson J.V., Lamond A., Forster A., Stinson M.A., Evan G., Fischer W., Atherton E., Sheppard R., Rabbitts T.H. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 1985, 4:2009-2015.
31. Hiyama H., Iavarone A., Reeves S.A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 1998, 16:1513-1523.
32. Rao G.N., Church R.L. Regulation of CAD gene expression in mouse fibroblasts during the transition from the resting to the growing state. Exp. Cell Res. 1988, 178:449-456.
33. Harbour J.W., Dean D.C. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2000, 2:E65-E67.
34. Wasylishen A.R., Penn L.Z. Myc: the beauty and the beast. Genes Cancer 2010, 1:532-541.
35. Yoo J., Jung J.H., Choi H.J., Kang S.J., Kang C.S. The expression of c-myc, bcl-2 and p53 proteins in adenocarcinomas of lung. Cancer Res. Treat. 2004, 36:146-150.
36. Parra M., Verdin E. Regulatory signal transduction pathways for class IIa histone deacetylases. Curr. Opin. Pharmacol. 2010, 10:454-460.
37. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 1999, 18:5099-5107.
38. Wang A.H., Kruhlak M.J., Wu J., Bertos N.R., Vezmar M., Posner B.I., Bazett-Jones D.P., Yang X.J. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 2000, 20:6904-6912.
39. Samara N.L., Wolberger C. A new chapter in the transcription SAGA. Curr. Opin. Struct. Biol. 2011, 21:767-774.
40. Sorokin A.V., Kim E.R., Ovchinnikov L.P. Nucleocytoplasmic transport of proteins. Biochemistry (Mosc) 2007, 72:1439-1457.
41. Grozinger C.M., Schreiber S.L., Wang A.H., Kruhlak M.J., Wu J., Bertos N.R., Vezmar M., Posner B.I., Bazett-Jones D.P., Yang X.J. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7835-7840.
42. Gocke C.B., Yu H., Kang J. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 2005, 280:5004-5012.
43. Ren J., Gao X., Jin C., Zhu M., Wang X., Shaw A., Wen L., Yao X., Xue Y. Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 2009, 9:3409-3412.
44. Giorgino F., de Robertis O., Laviola L., Montrone C., Perrini S., McCowen K.C., Smith R.J. The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1125-1130.
45. Perissi V., Jepsen K., Glass C.K., Rosenfeld M.G. Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 2010, 11:109-123.
46. Santoso B., Kadonaga J.T. Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300. Nat. Struct. Mol. Biol. 2006, 13:131-139.
47. Waltzer L., Bienz M. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature 1998, 395:521-525.
48. Chen H.M., La Thangue N.B. p300/CBP proteins: HAT for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
49. Sankar N., Baluchamy S., Kadeppagari R.K., Singhal G., Weitzman S., Thimmapaya B. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 2008, 27:5717-5728.
50. Zhao Y., Takeyama K., Sawatsubashi S., Ito S., Suzuki E., Yamagata K., Tanabe M., Kimura S., Fujiyama S., Ueda T., Murata T., Matsukawa H., Shirode Y., Kouzmenko A.P., Li F., Tabata T., Kato S. Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system. Mol. Cell. Biol. 2009, 29:1017-1034.
51. McDoniels-Silvers A.L., Nimri C.F., Stoner G.D., Lubet R.A., You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res. 2002, 8:1127-1138.
52. Ouyang J., Shi Y., Valin A., Xuan Y., Gill G. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell 2009, 34:145-154.
53. Chan J.K., Sun L., Yang X.J., Zhu G., Wu Z. Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J. Biol. Chem. 2003, 278:23515-23521.
54. Clocchiatti A., Florean C., Brancolini C. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. J. Cell. Mol. Med. 2011, 15:1833-1846.
55. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y.J., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
56. Shim H., Chun Y.S., Lewis B.C., Dang C.V. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1511-1516.
57. Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 2007, 178:93-105.
58. Barr L.F., Campbell S.E., Diette G.B., Gabrielson E.W., Kim S., Shim H., Dang C.V. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Cancer Res. 2000, 60:143-149.